We came across a bullish thesis on Gilead Sciences, Inc. on Dividend Talks’s Substack. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc.'s share was trading at $110.87 as of June 30th. GILD’s trailing and forward P/E were 23.29 and 14.01 respectively according to Yahoo Finance.
[caption id="attachment_1238765" align="aligncenter" width="768"]Gilead Sciences (GILD) is a leading biopharmaceutical company known for its expertise in antiviral...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.